Item 5.02.          Departure of Directors or Certain Officers; Election of Directors;
                    Appointment of Certain Officers; Compensatory Arrangements of Certain
                    Officers.

(a) On September 23, 2020, Donald Britton, a Class I member of the Board of Directors (the "Board") of SelectQuote, Inc. (the "Company"), notified the Company of his resignation from the Board effective on such date. Mr. Britton's resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.

(e) On September 23, 2020, the Board appointed Kavita K. Patel as a Class I member of the Board. Dr. Patel's term began upon her appointment and will run through the Company's annual meeting of stockholders in 2020. Further on September 23, 2020, the Board appointed Dr. Patel to the Nominating and Governance Committee of the Board. Since February 2011, Dr. Patel has been a Nonresident Fellow in the Department of Economic Studies at The Brookings Institution in Washington, DC. Since March 2020, she has been a practicing primary care physician at Mary's Center, a federally-qualified Health Center in Washington, DC. From August 2011 to August 2019, she was a practicing primary care physician at Johns Hopkins Medicine in Baltimore.

Dr. Patel will be compensated on the same basis as all other non-management Directors of the Company. Compensation for non-management directors is described each year in the Company's Proxy Statement under "Director Compensation". Dr. Patel is not and has not been involved in any related-party transactions with the Company required to be disclosed under Item 404 of Regulation S-K, and does not have any family relationships with any other director, executive officer, or any persons nominated for such positions.

Item 7.01 Regulation FD Disclosure.

On September 23, 2020, the Company issued a press release announcing the election of Dr. Patel to the Board. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d)  Exhibits
Exhibit No.    Description of Exhibit
  99.1         Press Release dated September 23, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses